Team Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3
Closed -$99 43
2023
Q4
$99 Hold
3
﹤0.01% 211
2023
Q3
$85 Buy
+3
New +$98 ﹤0.01% 198

Other funds holding ARKG

Team Financial Group's ARKG Position: Q1 2024 in Review

Team Financial Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 3 shares — an estimated $99 sold.

Team Financial Group first reported a position in ARKG in Q3 2023 and held it in 2 quarters. The position peaked at $99 in Q4 2023. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Team Financial Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
  • Team Financial Group sold 3 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $99.
  • Team Financial Group first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 2 quarters.
  • Team Financial Group's ARK Genomic Revolution ETF position peaked at $99 in Q4 2023.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Team Financial Group's 13F filing for Q1 2024, filed 13 May 2024.